<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pro-inflammatory cytokine interferon-gamma (IFNgamma) has traditionally been associated with inflammatory <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease and more recently with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced pathology </plain></SENT>
<SENT sid="1" pm="."><plain>Using a murine model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, we found no evidence for induction of IFNgamma <z:chebi fb="2" ids="33699">mRNA</z:chebi> after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, we found that mice deficient in IFNgamma or IFNgamma receptors developed neocortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> similar in size to those in <z:mp ids='MP_0002169'>wild type</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, MBP promoter-IFNgamma-transgenic mice consistently developed significantly larger <z:mpath ids='MPATH_124'>infarcts</z:mpath> than non-transgenic mice </plain></SENT>
<SENT sid="4" pm="."><plain>Because IFNgamma is a potent activator of microglia-macrophages, we investigated the involvement of microglial-macrophage-derived TNF in the larger <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Numbers of TNF <z:chebi fb="2" ids="33699">mRNA</z:chebi>-expressing microglia-macrophages and levels of TNF <z:chebi fb="2" ids="33699">mRNA</z:chebi> and TNF in IFNgamma-transgenic and non-transgenic mice were similar </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the ischemic brain damage in IFN-gamma-transgenic mice was unaffected by recombinant soluble TNF receptor I </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, the data argues against a role for IFNgamma in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> under <z:mpath ids='MPATH_458'>normal</z:mpath> conditions </plain></SENT>
<SENT sid="8" pm="."><plain>However, when present, IFNgamma significantly exacerbates <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced brain damage by mechanisms that appear to be independent of TNF or synergistic neurotoxic interactions of IFNgamma and TNF Irrespective of the mechanism(s) involved, this enhancing effect of IFNgamma on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neurotoxicity may need to be considered in diseases where immune IFNgamma is involved, such as multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
</text></document>